Copyright Reports & Markets. All rights reserved.

Impact of COVID-19 Outbreak on Vaccine for Influenza, Global Market Research Report 2020

Request for Sample of this report
Buy now

1 Vaccine for Influenza Market Overview

  • 1.1 Product Overview and Scope of Vaccine for Influenza
  • 1.2 Covid-19 Impact on Vaccine for Influenza Segment by Type
    • 1.2.1 Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2021-2026)
    • 1.2.2 Trivalent Influenza Vaccine
    • 1.2.3 Quadrivalent Influenza Vaccine
  • 1.3 Covid-19 Impact on Vaccine for Influenza Segment by Application
    • 1.3.1 Vaccine for Influenza Sales Comparison by Application: 2020 VS 2026
    • 1.3.2 For Children (6 months to 3 years)
    • 1.3.3 For Adults and Children over 3 years
  • 1.4 Covid-19 Impact on Global Vaccine for Influenza Market Size Estimates and Forecasts
    • 1.4.1 Global Vaccine for Influenza Revenue 2015-2026
    • 1.4.2 Global Vaccine for Influenza Sales 2015-2026
    • 1.4.3 Vaccine for Influenza Market Size by Region: 2020 Versus 2026
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Vaccine for Influenza Industry
  • 1.7 COVID-19 Impact: Vaccine for Influenza Market Trends

2 Covid-19 Impact on Global Vaccine for Influenza Market Competition by Manufacturers

  • 2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Vaccine for Influenza Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Vaccine for Influenza Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
  • 2.5 Vaccine for Influenza Market Competitive Situation and Trends
    • 2.5.1 Vaccine for Influenza Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Vaccine for Influenza Players (Opinion Leaders)

3 Covid-19 Impact on Vaccine for Influenza Retrospective Market Scenario by Region

  • 3.1 Global Vaccine for Influenza Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Vaccine for Influenza Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Vaccine for Influenza Market Facts & Figures by Country
    • 3.3.1 North America Vaccine for Influenza Sales by Country
    • 3.3.2 North America Vaccine for Influenza Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Vaccine for Influenza Market Facts & Figures by Country
    • 3.4.1 Europe Vaccine for Influenza Sales by Country
    • 3.4.2 Europe Vaccine for Influenza Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Vaccine for Influenza Sales by Region
    • 3.5.2 Asia Pacific Vaccine for Influenza Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Vaccine for Influenza Market Facts & Figures by Country
    • 3.6.1 Latin America Vaccine for Influenza Sales by Country
    • 3.6.2 Latin America Vaccine for Influenza Sales by Country
    • 3.6.3 Mexico
    • 3.6.3 Brazil
    • 3.6.3 Argentina
  • 3.7 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Vaccine for Influenza Sales by Country
    • 3.7.2 Middle East and Africa Vaccine for Influenza Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Covid-19 Impact on Global Vaccine for Influenza Historic Market Analysis by Type

  • 4.1 Global Vaccine for Influenza Sales Market Share by Type (2015-2020)
  • 4.2 Global Vaccine for Influenza Revenue Market Share by Type (2015-2020)
  • 4.3 Global Vaccine for Influenza Price Market Share by Type (2015-2020)
  • 4.4 Global Vaccine for Influenza Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global Vaccine for Influenza Historic Market Analysis by Application

  • 5.1 Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
  • 5.2 Global Vaccine for Influenza Revenue Market Share by Application (2015-2020)
  • 5.3 Global Vaccine for Influenza Price by Application (2015-2020)

6 Company Profiles and Key Figures in Vaccine for Influenza Business

  • 6.1 Sanofi
    • 6.1.1 Corporation Information
    • 6.1.2 Sanofi Description, Business Overview and Total Revenue
    • 6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Sanofi Products Offered
    • 6.1.5 Sanofi Recent Development and Response to COVID-19
  • 6.2 CSL
    • 6.2.1 CSL Corporation Information
    • 6.2.2 CSL Description, Business Overview and Total Revenue
    • 6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 CSL Products Offered
    • 6.2.5 CSL Recent Development and Response to COVID-19
  • 6.3 GSK
    • 6.3.1 GSK Corporation Information
    • 6.3.2 GSK Description, Business Overview and Total Revenue
    • 6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 GSK Products Offered
    • 6.3.5 GSK Recent Development and Response to COVID-19
  • 6.4 Mylan
    • 6.4.1 Mylan Corporation Information
    • 6.4.2 Mylan Description, Business Overview and Total Revenue
    • 6.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Mylan Products Offered
    • 6.4.5 Mylan Recent Development and Response to COVID-19
  • 6.5 Hulan Bio
    • 6.5.1 Hulan Bio Corporation Information
    • 6.5.2 Hulan Bio Description, Business Overview and Total Revenue
    • 6.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Hulan Bio Products Offered
    • 6.5.5 Hulan Bio Recent Development and Response to COVID-19
  • 6.6 AstraZeneca
    • 6.6.1 AstraZeneca Corporation Information
    • 6.6.2 AstraZeneca Description, Business Overview and Total Revenue
    • 6.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 AstraZeneca Products Offered
    • 6.6.5 AstraZeneca Recent Development and Response to COVID-19
  • 6.7 CCBIO
    • 6.6.1 CCBIO Corporation Information
    • 6.6.2 CCBIO Description, Business Overview and Total Revenue
    • 6.6.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 CCBIO Products Offered
    • 6.7.5 CCBIO Recent Development and Response to COVID-19

7 Vaccine for Influenza Manufacturing Cost Analysis

  • 7.1 Vaccine for Influenza Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Vaccine for Influenza
  • 7.4 Vaccine for Influenza Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Vaccine for Influenza Distributors List
  • 8.3 Vaccine for Influenza Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Vaccine for Influenza Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Vaccine for Influenza by Type (2021-2026)
  • 10.2 Vaccine for Influenza Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Vaccine for Influenza by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Vaccine for Influenza by Application (2021-2026)
  • 10.3 Vaccine for Influenza Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Vaccine for Influenza by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Vaccine for Influenza by Region (2021-2026)
  • 10.4 North America Vaccine for Influenza Estimates and Projections (2021-2026)
  • 10.5 Europe Vaccine for Influenza Estimates and Projections (2021-2026)
  • 10.6 Asia Pacific Vaccine for Influenza Estimates and Projections (2021-2026)
  • 10.7 Latin America Vaccine for Influenza Estimates and Projections (2021-2026)
  • 10.8 Middle East and Africa Vaccine for Influenza Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Vaccine for Influenza market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Vaccine for Influenza industry.

    Segment by Type, the Vaccine for Influenza market is segmented into
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

    Segment by Application
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

    Global Vaccine for Influenza Market: Regional Analysis
    The Vaccine for Influenza market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Vaccine for Influenza market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Vaccine for Influenza Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Vaccine for Influenza market include:
    Sanofi
    CSL
    GSK
    Mylan
    Hulan Bio
    AstraZeneca
    CCBIO
    Buy now